Consultant, US Market Access Strategy - Rare Disease

Description Remote Our client seeks a consultant to drive US market access strategy and launch readiness for a rare disease asset. The role advises on payer analytics, value narrative development, and field enablement to support access decisions across commercial and government channels. The consultant will translate evidence and data into strategic recommendations and partner across functions to ensure integrated launch planning. Due to client requirements, applicants must be willing and able to work on a w2 basis. For our w2 consultants, we offer a great benefits package that includes Medical, Dental, and Vision benefits, 401k with company matching, and life insurance. Rate: $80.00 to $70.00/hr. w2 Responsibilities Support development and refinement of US payer strategy for rare disease assets approaching launch. Conduct payer landscape and access risk assessments across commercial, Medicaid, and specialty payer segments. Pressure-test launch assumptions related to access timing, utilization management, and contracting scenarios. Provide structured recommendations on access-related risks and mitigation strategies. Shape the payer value narrative by translating clinical, unmet need, and HEOR inputs into payer-relevant messaging. Align the value story across national and regional payer audiences. Identify evidence or analytics gaps that could affect payer decision-making pre- and peri-launch. Analyze claims data, coverage policies, and utilization management trends to generate actionable insights. Translate data into clear strategic implications for market access leadership. Support payer segmentation and prioritization based on disease prevalence, payer controls, and policy trends. Enable field market access and account teams with payer insights, strategic talking points, and analytics-driven frameworks. Advise account teams on payer motivations, objections, and decision pathways in rare disease. Ensure field-facing materials are strategy-led and aligned with overall payer positioning. Collaborate with Market Access, Medical Affairs, HEOR, and Commercial Planning to drive integrated launch readiness. Act as a market access thought partner in a lean, fast-moving environment. Experience Requirements 7–12+ years in market access strategy, payer strategy, or life sciences consulting. Experience supporting rare disease and/or orphan product launches. Strong understanding of US payer dynamics, including managed care, specialty pharmacy, and utilization management. Ability to analyze complex data and convert insights into strategic recommendations. Experience operating in high ambiguity, early-stage, or pre-launch environments. #J-18808-Ljbffr Eliassen Group